1-215798994-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_206933.4(USH2A):c.9871G>A(p.Gly3291Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,613,984 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.9871G>A | p.Gly3291Ser | missense_variant | 50/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.9871G>A | p.Gly3291Ser | missense_variant | 50/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000674083.1 | c.9871G>A | p.Gly3291Ser | missense_variant | 50/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000263 AC: 66AN: 251216Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135760
GnomAD4 exome AF: 0.000422 AC: 617AN: 1461792Hom.: 1 Cov.: 32 AF XY: 0.000418 AC XY: 304AN XY: 727198
GnomAD4 genome AF: 0.000309 AC: 47AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 02, 2024 | Reported in the heterozygous state in a patient with Usher syndrome in published literature (PMID: 25333064); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32707200, 25333064) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 3291 of the USH2A protein (p.Gly3291Ser). This variant is present in population databases (rs138543813, gnomAD 0.05%). This missense change has been observed in individual(s) with Usher syndrome (PMID: 25333064). ClinVar contains an entry for this variant (Variation ID: 550545). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 31, 2017 | - - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 28, 2019 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 03, 2018 | The p.Gly3291Ser variant has been previously reported in one individual with Ush er syndrome; however the variant reported on the other allele (p.Tyr1992Cys) is classified as benign based on its frequency (Krawitz 2014). The p.Gly3291Ser var iant has been identified in 0.05% (59/126516) European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs1385438 13). Although this variant has been seen in the general population, its frequen cy is not high enough to rule out a pathogenic role. Computational prediction to ols and conservation analyses suggest that this variant may not impact the prote in, and at least one mammal (shrew) has a Serine at this residue as do other low er species (birds, reptiles, fish). In summary, the clinical significance of the p.Gly3291Ser variant is likely benign. ACMG/AMP Criteria applied: BP4_Strong. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at